A large-scale concordance study of toxicity findings across preclinical species and humans for small molecules and biologics
Translating preclinical safety findings into reliable insights for human risk assessment remains a fundamental challenge in drug development. Prior preclinical-clinical concordance studies have been constrained by limited drug coverage, reliance on identical-term matching for adverse events (AEs), a...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2026-04-01
|
| シリーズ: | Frontiers in Toxicology |
| 主題: | |
| オンライン･アクセス: | https://www.frontiersin.org/articles/10.3389/ftox.2026.1731947/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|